Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation

摘要

A method of treating a disease or disorder associated with inflammation or inappropriate complement activation which method comprises administering to a mammal in need thereof an effective amount of a soluble CR1 protein and an effective amount of an amidinophenyl or amidinonaphthyl ester, including pharmaceutically acceptable salts thereof.